IRINOTECAN HYDROCHLORIDE INJECTION, USP
Google image searchProduct monograph
Active ingredient
irinotecan hydrochloride (irinotecan hydrochloride trihydrate), 20 MG/ML
DIN: 02452421
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: 2/5/15/25ML SINGLE USE VIALS
Schedule: Prescription
Company: GENERIC MEDICAL PARTNERS INC
Date: 22-MAY-2024
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01C — PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS (ATC, ATC/DDD)
- L01CE — Topoisomerase 1 (TOP1) inhibitors (ATC, ATC/DDD)
- L01CE02 — IRINOTECAN (ATC/DDD)
Reference brand drug: Camptosar
Pharmaceutical standard: MFR
